SELECTED RESEARCH / 2026
Outcomes with GLP-1 versus SGLT2 therapies after liver transplantation
TriNetX data were used to compare cardiovascular, hepatic, and survival outcomes with two classes of glucose-lowering drugs in patients with diabetes after liver transplantation.
Read the research and translated summary